Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2013
10/30/2013EP2654727A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
10/30/2013EP2654421A1 Fused heterocyclic indane carboxamide cgrp receptor antagonists
10/30/2013CN203252935U Anti-senile and life-prolonging plaster
10/30/2013CN103380134A N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors
10/30/2013CN103380133A Compounds and their use as BACE inhibitors
10/30/2013CN103380131A Heteroaryl compounds as 5-ht4 receptor ligands
10/30/2013CN103380130A Novel pyrazole and imidazole derivatives useful as orexin antagonists
10/30/2013CN103380129A 2-carboxamide-4-piperazinyl-benzofuran derivative
10/30/2013CN103380122A Novel benzodioxole piperazine compounds
10/30/2013CN103380118A Tau成像探针 Tau imaging probe
10/30/2013CN103380112A Indole derivatives as modulators of S1P receptors
10/30/2013CN103379901A Formulations comprising methylthioninium chloride
10/30/2013CN103374552A PHF 8 (Plant Homedomain Finger Protein 8) protein fragment as well as prokaryotic expression and purification method and antibody thereof
10/30/2013CN103374079A Methylated fucus evanescens oligose or methylated sulfated fucus evanescens oligose or salt thereof as well as preparation method and application thereof
10/30/2013CN103374066A Alpha B-O-conotoxin and medicine composition and application thereof
10/30/2013CN103374057A New compound with inhibiting activity to glycine transporters
10/30/2013CN103373994A Therapeutic compounds
10/30/2013CN103373957A Chelate with functions of protecting nerve cells
10/30/2013CN103373905A Biphenyl polyphenol compound with acetyl choline and butyrylcholine esterase inhibiting effect and use of compound
10/30/2013CN103372218A microRNA related to autoimmune disease and application thereof
10/30/2013CN103372199A Novel brain targeting preparation for preventing and treating neurodegenerative disease
10/30/2013CN103372183A Pharmaceutical composition for treating cervical vertebra and lumbar vertebra diseases
10/30/2013CN103372174A Compound traditional Chinese medicine for treating depression
10/30/2013CN103372152A Folk prescription for relieving trigeminal neuralgia
10/30/2013CN103372146A Externally applied medicine for treating facial distortion and production method thereof
10/30/2013CN103372144A Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof
10/30/2013CN103372135A Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance
10/30/2013CN103372126A Chinese medicinal composition for treating hemicrania
10/30/2013CN103372118A Chinese medicinal composition for treating forehead pain
10/30/2013CN103372116A Fire therapy liquid
10/30/2013CN103372104A Refreshing agent
10/30/2013CN103372095A Chinese medicinal composition for treating eye-mouth deviation
10/30/2013CN103372080A Preparation method of medicinal liquid for treating pain and numbness of limbs
10/30/2013CN103372079A Chinese medicinal composition for treating tinnitus cerebri
10/30/2013CN103372071A Pharmaceutical composition for treating insomnia
10/30/2013CN103372057A Preparation method of lignans
10/30/2013CN103372044A Medicament for treating hemicranias, and application thereof in preparation of nose drop for treating hemicranias
10/30/2013CN103372034A Preparation method of ginkgo biloba extract
10/30/2013CN103372024A An inhibitor of the production of advanced glycation end products
10/30/2013CN103372023A Application of chitosan oligosaccharide in preparation of medicaments for preventing and/or treating neurodegenerative diseases
10/30/2013CN103371993A Application of n-3 unsaturated fatty acid in preparation of medicine for preventing and treating traumatic brain injury
10/30/2013CN103371982A Novel prescription composition and preparation method of paroxetine hydrochloride enteric controlled release tablet
10/30/2013CN102885868B Application of Pien Tze Huang and preparation of Pien Tze Huang to protection of memory function and resistance of cerebral ischemia
10/30/2013CN102793863B Preparation method of traditional Chinese medicine for treating fundus congestion type insomnia
10/30/2013CN102793851B Preparation method of traditional Chinese medicine for treating blood stasis type insomnia
10/30/2013CN102698050B Traditional Chinese medicine for treating insomnia
10/30/2013CN102657686B Application of sea-buckthorn seed oil to preparation of medicament for preventing and/or treating depression
10/30/2013CN102600348B Medicine for treating insomnia and preparation method thereof
10/30/2013CN102579416B Application of carmustine to prepare drugs for preventing and/or treating psychoactive drug substance dependency and relapse
10/30/2013CN102526377B Chinese medicinal herb tea for contributing to cardiovascular and cerebrovascular diseases and promoting sleeping and preparation method thereof
10/30/2013CN102406730B Traditional Chinese preparation for treating multiple peripheral neuritis
10/30/2013CN102397526B Application of Jingzhaotoxin-V to preparation of medicine for resisting cognitive, learning and memory dysfunction
10/30/2013CN102381972B Propofol hydroxy acid ester compound with ester constitutional terminal, preparation method for same and application thereof
10/30/2013CN102379873B Acute general Parkinson's disease monkey model and medicament screening method thereof
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102225896B Ether derivatives of rhein and their therapeutic use
10/30/2013CN102188693B Proteoglycan complex
10/30/2013CN102180971B Recombinant beta-amyloid peptide B cell epitope polypeptide chimeric antigen and preparation method and application thereof
10/30/2013CN102127006B Production method of donepezil hydrochloride
10/30/2013CN102099344B Imidazole carboxamides
10/30/2013CN102078322B Medical purpose of piperacillin sodium and tazobactam sodium for injection
10/30/2013CN101951923B Liquid nucleotides/nucleosides-containing product
10/30/2013CN101835770B Condensed compounds with activity at estrogen receptors
10/30/2013CN101780075B Combined drug for treating insomnia
10/30/2013CN101768202B Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof
10/30/2013CN101687927B Antibody directed to G protein coupled receptors (GPCR)
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101528712B Substituted benzimidazolone derivatives, medicaments comprising them and their use
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/30/2013CN101503414B Thiazolo[3,2-b]-1,2,4-triazine derivative and use thereof
10/30/2013CN101495135B Treatment of pain by use of single chain polypeptide fusion protein
10/30/2013CN101415464B Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
10/30/2013CN101084215B Piperidine and azetidine derivatives as GLYT1 inhibitors
10/30/2013CN101023066B Substituted triazines as prion protein ligands and their use to detect or remove prions
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569289 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
10/29/2013US8569285 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
10/29/2013US8569248 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
10/29/2013US8569227 Stabilized fibronectin domain compositions, methods and uses
10/29/2013US8569058 Nerve regeneration promoters
10/29/2013US8568972 Substances causing differentiation
10/29/2013US8568805 Cognitive function
10/29/2013US8568799 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
10/29/2013CA2630441C Therapeutic uses of steroidal compounds
10/29/2013CA2620179C Inhibitors of voltage-gated sodium channels
10/29/2013CA2605473C Process for preparing quetiapine and quetiapine fumarate
10/29/2013CA2595519C Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/29/2013CA2593274C Glycine reuptake inhibitors for treating drug and alcohol dependence
10/29/2013CA2582273C Compositions and methods for treating cognitive disorders using serotonin receptor antagonists
10/29/2013CA2563038C Neurologically-active compounds
10/29/2013CA2529268C Pharmaceutical formulations of amyloid inhibiting compounds
10/29/2013CA2509136C Human il-1 beta antagonists
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/24/2013WO2013158739A1 Neuroprotective composition and method of use
10/24/2013WO2013158628A1 Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria
10/24/2013WO2013158121A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013WO2013157555A1 Novel aplysiatoxin derivative and anticancer agent containing same
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013WO2013156955A1 Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (adhd)
10/24/2013WO2013156850A1 Systems and methods for treating an opioid-induced adverse pharmacodynamic response
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 1833